Avelumab in G2-3 NET
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
- Status
- COMPLETED
- Phase
- PHASE2
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
- Status
- COMPLETED
- Phase
- PHASE2
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain
- Status
- COMPLETED
- Phase
- N/A
MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents
- Status
- COMPLETED
- Phase
- NA
Entinostat Neuroendocrine (NE) Tumor
- Status
- TERMINATED
- Phase
- PHASE2
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Proton Boost for Locally Advanced HEAD AND NECK TUMORS
- Status
- COMPLETED
- Phase
- NA
Study of JS001 in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan
- Status
- COMPLETED
- Phase
- PHASE3
Biomarker Study in Pancreatic Neuroendocrine Tumours
- Status
- UNKNOWN
- Phase
- N/A
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- N/A
Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET
- Status
- UNKNOWN
- Phase
- PHASE4
TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3